ABVC BioPharma Restructures Joint Venture With Lucida
ABVC Biopharma, Inc. (NASDAQ:ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced the execution of a joint venture agreement